Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AIMday Antimicrobial Resistance - registration for academics now open

Events General Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes?

If you answer YES to any of the above, now is the time to register for the AIMday in Antimicrobial Resistance.

The event takes place on Thursday 4 July at the Blavatnik School of Government and is hosted by The University of Oxford, together with the NIHR Community Healthcare MIC.

FREE registration for academics is now open and closes on Thursday 27 June (advance registration is essential).

A range of companies are registered to attend, and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions.

Companies registered to attend

  • Abbott
  • Academic Health Science Network for the North East and North Cumbria
  • Amprologix
  • Astrego Diagnostics
  • Centauri Therapeutics
  • Destiny Pharma
  • Evotec
  • GeneFirst
  • GSK
  • Ingenza
  • Innovate UK
  • metaLinear
  • Oppilotech
  • Oxford Drug Design
  • Pedanius Therapeutics
  • Randox Laboratories
  • Release Life Sciences and Diagnostics
  • Summit Therapeutics
  • Thermo Fisher Scientific

To see the questions posed by these companies, please visit aimday.se/amr-2019/questions-listing.

Register here: http://aimday.se/amr-oxford-2019. 

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

Cognitive behavioural therapy: we discovered a data gap on its effectiveness for different ethnic groups

General Research

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.